Evidence map›Paper›PMID 26292731›Full record

ArticleNature communications2015

Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells.

Sergio Ruiz, Andres J Lopez-Contreras, Mathieu Gabut, Rosa M Marion, Paula Gutierrez-Martinez, Sabela Bua, Oscar Ramirez, Iñigo Olalde, Sara Rodrigo-Perez, Han Li and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Phosphorylation and DNA damage resolution coordinate SOX2-mediated reprogramming in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Morphogen Gradients as Drivers of Mosaicism During Early Human Development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Sergio RuizGenomic Instability Group, Spanish National Cancer Research Centre, 3, Melchor Fernandez Almagro, 28029 Madrid, Spain.
Andres J Lopez-ContrerasGenomic Instability Group, Spanish National Cancer Research Centre, 3, Melchor Fernandez Almagro, 28029 Madrid, Spain.
Mathieu GabutOntario Institute for Cancer Research, Toronto, Ontario, Canada M5G 0A3.
Rosa M MarionTelomeres and Telomerase Group, Spanish National Cancer Research Centre, 28029 Madrid, Spain.
Paula Gutierrez-MartinezGenomic Instability Group, Spanish National Cancer Research Centre, 3, Melchor Fernandez Almagro, 28029 Madrid, Spain.
Sabela BuaCellular Plasticity and Disease Modelling group, Department of Developmental and Stem Cell Biology, Institut Pasteur, 75015 Paris, France.
Oscar RamirezICREA at the Institut de Biologia Evolutiva (Universitat Pompeu Fabra/CSIC), 08003 Barcelona, Spain.
Iñigo OlaldeICREA at the Institut de Biologia Evolutiva (Universitat Pompeu Fabra/CSIC), 08003 Barcelona, Spain.
Sara Rodrigo-PerezGenomic Instability Group, Spanish National Cancer Research Centre, 3, Melchor Fernandez Almagro, 28029 Madrid, Spain.
Han LiCellular Plasticity and Disease Modelling group, Department of Developmental and Stem Cell Biology, Institut Pasteur, 75015 Paris, France.
Tomas Marques-BonetICREA at the Institut de Biologia Evolutiva (Universitat Pompeu Fabra/CSIC), 08003 Barcelona, Spain.
Manuel SerranoTumor Supression Group, Spanish National Cancer Research Centre, 28029 Madrid, Spain.
Maria A BlascoTelomeres and Telomerase Group, Spanish National Cancer Research Centre, 28029 Madrid, Spain.
Nizar N BatadaOntario Institute for Cancer Research, Toronto, Ontario, Canada M5G 0A3.
Oscar Fernandez-CapetilloGenomic Instability Group, Spanish National Cancer Research Centre, 3, Melchor Fernandez Almagro, 28029 Madrid, Spain.
Spanish National Cancer Research Centre · ESInstitut de Biologia Evolutiva · ESInstitut Pasteur · FROntario Institute for Cancer Research · CAPompeu Fabra University · ES

Funding

European Research Council 260372European Research Council 617840Howard Hughes Medical InstituteWorldwide Cancer Research 12-0229
6 · The paper itself

Abstract

The generation of induced pluripotent stem cells (iPSC) from adult somatic cells is one of the most remarkable discoveries in recent decades. However, several works have reported evidence of genomic instability in iPSC, raising concerns on their biomedical use. The reasons behind the genomic instability observed in iPSC remain mostly unknown. Here we show that, similar to the phenomenon of oncogene-induced replication stress, the expression of reprogramming factors induces replication stress. Increasing the levels of the checkpoint kinase 1 (CHK1) reduces reprogramming-induced replication stress and increases the efficiency of iPSC generation. Similarly, nucleoside supplementation during reprogramming reduces the load of DNA damage and genomic rearrangements on iPSC. Our data reveal that lowering replication stress during reprogramming, genetically or chemically, provides a simple strategy to reduce genomic instability on mouse and human iPSC.

Indexed as

AnimalsCell LineCell ProliferationCellular ReprogrammingCheckpoint Kinase 1DNAFibroblastsGene Expression RegulationGenomic InstabilityHumansInduced Pluripotent Stem CellsMiceMice, TransgenicNucleic Acid HybridizationPlasmidsPoint MutationCheckpoint Kinase 1CHEK1 protein, humanChek1 protein, mouseDNAProtein Kinases

Identifiers

PMID26292731
PMCPMC4560784
OpenAlexW2259926819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.